![Getinge AB, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/051c381c-a7e1-4700-9aaf-5c6024766550.png)
Kirjaudu sisään Inderes Free -tilillesi nähdäksesi kaikki sivun maksuton sisältö.
Getinge
208,8 SEK −0,19%5 sijoittajaa seuraa yhtiötä
Getinge is a global provider of technical solutions for the healthcare industry. The company is a developer and manufacturer of solutions used in operating rooms, intensive care units, and sterile facilities. The company's products are used, for example, for infection control, among IT systems, patient management, and in the care of severely obese patients. The head office is located in Gothenburg.
Liikevaihto
-
EBIT %
-
P/E -luku
23,57
Osinkotuotto %
-
Tavoitehinta
-
Suositus
-
Päivitetty
-
NASDAQ Stockholm
GETI B
Päivän matalin / päivän korkein hinta
207,4 / 209,9
SEK
Markkina-arvo
56,87 mrd. SEK
Vaihto
77,6 milj. SEK
Vaihtomäärä, kappaletta
372 t.
Viimeisimmät videot
Pörssikalenteri
Osavuosikatsaus
18.10.2024
Suurimmat omistajatLähde: Millistream Market Data AB
Omistaja | Osuus | Ääniä |
---|---|---|
Carl Bennet AB | 20,0 % | 50,1 % |
Fjärde AP-fonden | 7,4 % | 4,6 % |
Inderes Premium
Tämä sisältö on vain Inderes Premium -käyttäjille.
NäytäKaikki sisältötyypit
![Getinge AB, Audiocast with teleconference, Q2'24](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/051c381c-a7e1-4700-9aaf-5c6024766550.png)
Getinge Interim Report April-June 2024: Higher sales, stronger margins and product launches with significant added value for customers
Modular Finance IR Consensus: Getinge – Consensus estimates Q2 2024
Liity Inderesin yhteisöön
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.
FREE-tili
Pörssin suosituin aamukatsaus
Analyytikon kommentit ja suositukset
Osakevertailu
PREMIUM-tili
Kaikki yhtiöraportit ja sisällöt
Premium-työkalut (mm. sisäpiirin kaupat ja screeneri)
Mallisalkku
Getinge invites fund managers, analysts, and media to Q2 Report 2024 conference call
![Getinge, Audiocast with teleconference, 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/ddf5a336-5bdb-492f-96c8-9dfba7a27033.png)
Getinge, Audiocast with teleconference, 2024
Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average
Getinge invites fund managers, analysts and media to a Capital Market Update conference call
Resolutions at Getinge's Annual General Meeting 22 April 2024
![Getinge AB, Audiocast with teleconference, Q1, 2024](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/48725803-8db0-4670-9e0c-33775f791ed7.png)
Getinge AB, Audiocast with teleconference, Q1, 2024
Getinge Interim Report January-March 2024: Higher sales, strong cash flow and new products creating more customer value
Getinge invites fund managers, analysts, and media to Q1 Report 2024 conference call
Getinge publishes 2023 annual report
Getinge: NOTICE OF ANNUAL GENERAL MEETING IN GETINGE AB (PUBL)
Getinge takes a leap forward in cardiovascular surgery with the 510(k) clearance for Vasoview Hemopro 3
TÜV SÜD is temporarily suspending Getinge's CE certificate for Cardiosave
![Getinge AB, Audiocast with teleconference, Q4, 2023](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/b663d89e-fa6a-475d-ba4f-638b8979ffe3.png)
Getinge AB, Audiocast with teleconference, Q4, 2023
Getinge Year End Report 2023: Strong sales and healthy cash flow - but margins impacted by quality costs and mix effects
Agneta Palmér appointed new CFO of Getinge
Getinge invites fund managers, analysts, and media to Year-End Report 2023 conference call
![Getinge AB, Audiocast with teleconference, Q3, 2023](https://www.inderes.se/cdn-cgi/image/format=auto,width=640,height=358,quality=90,fit=cover/https://content.inderes.se/assets/19cff160-ba1e-42bb-b2a0-58c1d3724a71.png)